174 related articles for article (PubMed ID: 35360018)
1. Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis.
Bracco Gartner TCL; Crnko S; Leiteris L; van Adrichem I; van Laake LW; Bouten CVC; Goumans MJ; Suyker WJL; Sluijter JPG; Hjortnaes J
Front Cardiovasc Med; 2022; 9():854314. PubMed ID: 35360018
[TBL] [Abstract][Full Text] [Related]
2. Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis.
Bracco Gartner TCL; Deddens JC; Mol EA; Magin Ferrer M; van Laake LW; Bouten CVC; Khademhosseini A; Doevendans PA; Suyker WJL; Sluijter JPG; Hjortnaes J
Front Cardiovasc Med; 2019; 6():52. PubMed ID: 31080805
[TBL] [Abstract][Full Text] [Related]
3. Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling.
Sadeghi AH; Shin SR; Deddens JC; Fratta G; Mandla S; Yazdi IK; Prakash G; Antona S; Demarchi D; Buijsrogge MP; Sluijter JPG; Hjortnaes J; Khademhosseini A
Adv Healthc Mater; 2017 Jun; 6(11):. PubMed ID: 28498548
[TBL] [Abstract][Full Text] [Related]
4. Cardiac fibrosis models using human induced pluripotent stem cell-derived cardiac tissues allow anti-fibrotic drug screening in vitro.
Iseoka H; Miyagawa S; Sakai Y; Sawa Y
Stem Cell Res; 2021 Jul; 54():102420. PubMed ID: 34126557
[TBL] [Abstract][Full Text] [Related]
5. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients.
Zanotti S; Bragato C; Zucchella A; Maggi L; Mantegazza R; Morandi L; Mora M
Life Sci; 2016 Jan; 145():127-36. PubMed ID: 26679108
[TBL] [Abstract][Full Text] [Related]
7. Activated Cardiac Fibroblasts Control Contraction of Human Fibrotic Cardiac Microtissues by a β-Adrenoreceptor-Dependent Mechanism.
Błyszczuk P; Zuppinger C; Costa A; Nurzynska D; Di Meglio FD; Stellato M; Agarkova I; Smith GL; Distler O; Kania G
Cells; 2020 May; 9(5):. PubMed ID: 32443848
[TBL] [Abstract][Full Text] [Related]
8. Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing.
Mastikhina O; Moon BU; Williams K; Hatkar R; Gustafson D; Mourad O; Sun X; Koo M; Lam AYL; Sun Y; Fish JE; Young EWK; Nunes SS
Biomaterials; 2020 Mar; 233():119741. PubMed ID: 31927251
[TBL] [Abstract][Full Text] [Related]
9. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
10. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue.
Li Y; Asfour H; Bursac N
Acta Biomater; 2017 Jun; 55():120-130. PubMed ID: 28455218
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocytes facing fibrotic conditions re-express extracellular matrix transcripts.
Heras-Bautista CO; Mikhael N; Lam J; Shinde V; Katsen-Globa A; Dieluweit S; Molcanyi M; Uvarov V; Jütten P; Sahito RGA; Mederos-Henry F; Piechot A; Brockmeier K; Hescheler J; Sachinidis A; Pfannkuche K
Acta Biomater; 2019 Apr; 89():180-192. PubMed ID: 30862552
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
14. Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis.
Zhang H; Tian L; Shen M; Tu C; Wu H; Gu M; Paik DT; Wu JC
Circ Res; 2019 Aug; 125(5):552-566. PubMed ID: 31288631
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of anti-fibrotic natural compound similars with improved effectivity.
Kreutzer FP; Meinecke A; Mitzka S; Hunkler HJ; Hobuß L; Abbas N; Geffers R; Weusthoff J; Xiao K; Jonigk DD; Fiedler J; Thum T
Basic Res Cardiol; 2022 Mar; 117(1):9. PubMed ID: 35235052
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic Electrospun Scaffold-Based In Vitro Model Resembling the Hallmarks of Human Myocardial Fibrotic Tissue.
Ruocco G; Zoso A; Mortati L; Carmagnola I; Chiono V
ACS Biomater Sci Eng; 2023 Jul; 9(7):4368-4380. PubMed ID: 37289177
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone as a novel cardiac protective treatment.
Aimo A; Spitaleri G; Panichella G; Lupón J; Emdin M; Bayes-Genis A
Heart Fail Rev; 2022 Mar; 27(2):525-532. PubMed ID: 34671871
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.
Schimmel K; Ichimura K; Reddy S; Haddad F; Spiekerkoetter E
Front Cardiovasc Med; 2022; 9():886553. PubMed ID: 35600469
[TBL] [Abstract][Full Text] [Related]
20. A dynamic microscale mid-throughput fibrosis model to investigate the effects of different ratios of cardiomyocytes and fibroblasts.
Mainardi A; Carminati F; Ugolini GS; Occhetta P; Isu G; Robles Diaz D; Reid G; Visone R; Rasponi M; Marsano A
Lab Chip; 2021 Oct; 21(21):4177-4195. PubMed ID: 34545378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
